Cargando…
Early triple antiviral therapy for COVID-19 – Authors' reply
Autores principales: | Hung, Ivan Fan-Ngai, Yuen, Kwok-Yung |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Ltd.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7832612/ https://www.ncbi.nlm.nih.gov/pubmed/33160568 http://dx.doi.org/10.1016/S0140-6736(20)32268-6 |
Ejemplares similares
-
Early triple antiviral therapy for COVID-19
por: Lee, Nelson, et al.
Publicado: (2020) -
Combining immunomodulators and antivirals for COVID-19 – Authors' reply
por: Almansa, Raquel, et al.
Publicado: (2021) -
Seroprevalence of SARS-CoV-2 in Hong Kong returnees – Authors' reply
por: To, Kelvin Kai-Wang, et al.
Publicado: (2020) -
High-dose budesonide for early COVID-19 – Authors' reply
por: Hobbs, F D Richard, et al.
Publicado: (2021) -
Inhaled budesonide for early treatment of COVID-19 – Authors' reply
por: Ramakrishnan, Sanjay, et al.
Publicado: (2021)